Ari, Csilla http://orcid.org/0000-0002-8677-823X
Kovács, Zsolt
Murdun, Cem
Koutnik, Andrew P.
Goldhagen, Craig R.
Rogers, Christopher
Diamond, David
D’Agostino, Dominic P.
Funding for this research was provided by:
Office of Naval Research Global (N000141310062)
National Development Agency of Hungary (TIOP-1.3.1.-07/2-2F-2009-2008)
Glucose Transporter Type 1 Deficiency Foundation (6143109500)
Quest Nutrition LLC
Article History
Received: 17 October 2017
Accepted: 27 June 2018
First Online: 18 July 2018
Ethics approval and consent to participate
: Animal treatments were carried out according to the University of South Florida Institutional Animal Care and Use Committee (IACUC) guidelines (Protocol #00001749 and # 00000457), Hungarian Act of Animal Care and Experimentation (1998, XXVIII, section 243), European Communities Council Directive 24 November 1986 (86/609/EEC) and EU Directive 2010/63/EU to use and treat animals in experimental laboratories. The experimental design was approved by the Animal Care and Experimentation Committee of the Eötvös Loránd University (Savaria Campus) and National Scientific Ethical Committee on Animal Experimentation (Hungary) under license number VA/ÉBNTF02/85–8/2016.
: Not applicable.
: International Patent # PCT/US2014/031237, University of South Florida for DPD: “Compositions and Methods for Producing Elevated and Sustained Ketosis”. Non provisional patent No. 210112–9018-US01 for CA and DPD: “Methods of Increasing Latency to Anesthetic Induction using Ketone Supplementation”. Technology Title: “Methods of Increasing Latency of Anesthetic Induction Using Ketone Supplementation”. All authors declare that there are no additional conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.